MED-CARE ADVANTAGE Trademark
Trademark Overview
On Monday, August 26, 1991, a trademark application was filed for MED-CARE ADVANTAGE with the United States Patent and Trademark Office. The USPTO has given the MED-CARE ADVANTAGE trademark a serial number of 74198415. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 29, 1992. This trademark is owned by MEL BALISKY ENTERPRISES, INC.. The MED-CARE ADVANTAGE trademark is filed in the Advertising, Business and Retail Services category with the following description:
advertising and marketing of a program of Medicare Supplement insurance policies
General Information
Serial Number | 74198415 |
Word Mark | MED-CARE ADVANTAGE |
Filing Date | Monday, August 26, 1991 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, September 29, 1992 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | advertising and marketing of a program of Medicare Supplement insurance policies |
Pseudo Mark | MEDICAL CARE ADVANTAGE |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 101, 102 |
Class Status Code | 8 - Abandoned |
Class Status Date | Wednesday, August 4, 1999 |
Primary Code | 035 |
First Use Anywhere Date | Sunday, March 31, 1991 |
First Use In Commerce Date | Sunday, March 31, 1991 |
Trademark Owner History
Party Name | MEL BALISKY ENTERPRISES, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Chula Vista, CA 92010 |
Trademark Events
Event Date | Event Description |
Tuesday, September 29, 1992 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, February 21, 1992 | NON-FINAL ACTION MAILED |
Wednesday, December 4, 1991 | ASSIGNED TO EXAMINER |